The DOI matches its Crossref record; 122 of the 124 references it cites were found in a registry or an index.
Tumor microenvironment and therapeutic response
Abstract
The tumor microenvironment significantly influences therapeutic response and clinical outcome. Microenvironment-mediated drug resistance can be induced by soluble factors secreted by tumor or stromal cells. The adhesion of tumor cells to stromal fibroblasts or to components of the extracellular matrix can also blunt therapeutic response. Microenvironment-targeted therapy strategies include inhibition of the extracellular ligand-receptor interactions and downstream pathways. Immune cells can both improve and obstruct therapeutic efficacy and may vary in their activation status within the tumor microenvironment; thus, re-programme of the immune response would be substantially more beneficial. The development of rational drug combinations that can simultaneously target tumor cells and the microenvironment may represent a solution to overcome therapeutic resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent studies reported that alteration of tumour immune microenvironment in gastric cancer is a pivotal strategy for predicting the immunotherapeutic responses and prognosis, which might provide new treatment strategies for patients [26, 27].”
From Phosphoserine phosphatase as a prognostic biomarker in patients with gastric cancer and its potential association with immune cells (2022) · cites this paper as [26]
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,338
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
Immunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Pyonteck, S. M., Akkari, L., Schuhmacher, A. J., Bowman, R. L., Sevenich, L., Quail, D. F., Olson, O. C., Quick, M. L., Huse, J. T., Teijeiro, V., et al. (2013) · Nature Medicine · doi:10.1038/nm.3337 · Cited by 2,463
Macrophage plasticity and polarization in tissue repair and remodelling
Mantovani, A., Biswas, S. K., Galdiero, M. R., Sica, A., & Locati, M. (2013) · The Journal of Pathology · doi:10.1002/path.4133 · Cited by 2,384
Flagged first, then by citations
2 of the 124 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Zou, Y., Lü, N., Yang, X., Xie, Z., Lei, X., Liu, X., Li, Y., Sheng, H., Tang, G., & Wang, Z. (2023) · RSC Medicinal Chemistry · doi:10.1039/d3md00128h · Cited by 10
The development of an anti-cancer peptide M1-21 targeting transcription factor FOXM1
Cheng, H., Yuan, J., Pei, C., Ouyang, M., Bu, H., Chen, Y., Huang, X., Zhang, Z., Li, Y., & Tan, Y. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01059-7 · Cited by 10
Chen, W., Gu, T., Chen, Q., Qu, C., Zhang, C., Hu, Y., Xia, R., Zhang, Y., Wang, M., Huang, X., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01071-x · Cited by 10
Chen, Z., Li, R., Fang, M., Wang, Y., Bi, A., Yang, L., Song, T., Li, Y., Li, Q., Lin, B., et al. (2023) · International Journal of Medical Sciences · doi:10.7150/ijms.84872 · Cited by 10
A role for platelets in metabolic reprogramming of tumor-associated macrophages
Kang, Y., Amoafo, E. B., Entsie, P., Beatty, G. L., & Liverani, E. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1250982 · Cited by 10
Sun, J.-R., Kong, C., Ye, Y., Wang, Q., Qu, X.-K., Jia, L., & Wu, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-57714-7 · Cited by 12
Wang, S., Su, D., Chen, H., Lai, J.-C., Tang, C., Yu, L., Wang, Y., Yang, Y., Qin, M., Jia, L., et al. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01317-2 · Cited by 10
Lai, L., Xiong, Z., Ma, L., & Chen, T. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c09919 · Cited by 10
Fu, X., Luo, H., Zheng, Y., Wang, S., Zhong, Z., Wang, Y., & Yang, Y. (2020) · Aging · doi:10.18632/aging.103765 · Cited by 10
Xing, X., Yao, Z.-Y., Xing, C., Huang, Z., Peng, J., & Liu, Y. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-00966-3 · Cited by 10
Liu, R., Li, S., Liu, L.-Q., Xu, B., & Chen, M. (2021) · Bioengineered · doi:10.1080/21655979.2021.1936831 · Cited by 10
Guo, L., Zhang, X., Pan, H., Li, Y., Wang, J., Li, L., Dong, Y., Du, X., Chen, J., & Guo, F. (2021) · Bioengineered · doi:10.1080/21655979.2021.1955511 · Cited by 10
Mazilu, L., Suceveanu, A., Stănculeanu, D. L., Gheorghe, A. D., Fricatel, G., & Negru, Ș.-M. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10562 · Cited by 10
Zheng, B., Xie, F., Cheng, F., Wang, J., Yao, Z., He, W., & Niu, Z. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.760031 · Cited by 10
Role of the CBX Molecular Family in Lung Adenocarcinoma Tumorigenesis and Immune Infiltration
Zhang, C., Chang, L., Yao, Y., Chao, C., Ge, Z., Fan, C., Yu, H., Wang, B., & Yang, J. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.771062 · Cited by 10
Development of a Prognostic Model Based on Pyroptosis-Related Genes in Pancreatic Adenocarcinoma
Su, K., Peng, Y., & Yu, H. (2022) · Disease Markers · doi:10.1155/2022/9141117 · Cited by 10
Promoting Best Practice in Cancer Care in Sub Saharan Africa
Sharma, K., Sayed, S., & Saleh, M. N. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.950309 · Cited by 10
Wu, H., Zhong, W., Zhang, R., Ding, Y., Sun, B., Qu, C., Lai, K., Pang, Z., Yin, S., Sun, T., et al. (2023) · Cancer Medicine · doi:10.1002/cam4.5721 · Cited by 10
Renewed interests in carbonic anhydrase IX in relevance to breast cancer treatment
Dolatkhah, M., & Omidi, Y. (2019) · Bioimpacts · doi:10.15171/bi.2019.24 · Cited by 10
Chen, L., Zhou, X., Gao, Y., & Sui, X. (2022) · Pharmaceuticals · doi:10.3390/ph15050605 · Cited by 9
Identification of an Immune-Related Prognostic Risk Model in Glioblastoma
Lin, Z., Wang, R., Huang, C., He, H., OuYang, C., Li, H., Zhong, Z., Guo, J., Chen, X., Yang, C., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.926122 · Cited by 9
Wang, L., Sun, X.-D., He, J., & Liu, Z. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.781686 · Cited by 9
Wang, J., Chen, H., Deng, Q., Chen, Y., Wang, Z., Yan, Z., Wang, Y., Tang, H.-X., Liang, H., & Jiang, Y. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2022.1022626 · Cited by 9
Role of Epiregulin in Lung Tumorigenesis and Therapeutic Resistance
Sunaga, N., Miura, Y., Masuda, T., & Sakurai, R. (2024) · Cancers · doi:10.3390/cancers16040710 · Cited by 9
Carvalho, T. M. A., Audero, M. M., Greco, M. R., Ardone, M., Maggi, T., Mallamaci, R., Rolando, B., Arpicco, S., Ruffinatti, F. A., Fiorio, A., et al. (2024) · Cells · doi:10.3390/cells13090730 · Cited by 9
Naei, V. Y., Monkman, J. H., Sadeghirad, H., Mehdi, A. M., Blick, T., Mullally, W. J., O'Byrne, K. J., Warkiani, M. E., & Kulasinghe, A. (2024) · Clinical & Translational Immunology · doi:10.1002/cti2.1522 · Cited by 9
Wang, H., Chu, D., Zhang, M., Huang, X., Shi, Y., Zhao, Y. Y., Qu, H., Li, D., Xu, Z., Gao, L., et al. (2024) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2024.114398 · Cited by 9
Jiang, W., Xu, S. Y., Zhao, M., & Li, C. (2024) · Scientific Reports · doi:10.1038/s41598-024-79417-9 · Cited by 9
Lyu, F., Zhong, Y., He, Q., Xiao, W., & Zhang, X. (2025) · BMC Cancer · doi:10.1186/s12885-025-13534-0 · Cited by 9
4D printed hydrogels for precision delivery of bioactive molecules in cancer
Gato-Diaz, U., Concheiro, Á., Alvarez‐Lorenzo, C., & Blanco‐Fernandez, B. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2539959 · Cited by 9
Research Strategies and Methods of Hydrogels for Antitumor Drug Delivery
Zeng, T., Chen, L., Yoshitomi, T., Kawazoe, N., Yang, Y., & Chen, G. (2025) · Biomedicines · doi:10.3390/biomedicines13081899 · Cited by 10
Zhao, Q., Zhang, H., & Xing, W. (2025) · Technology in Cancer Research & Treatment · doi:10.1177/15330338251374945 · Cited by 9
Human sperm-associated antigen 4 as a potential prognostic biomarker of lung squamous cell carcinoma
Wang, Y., Tang, Y., Li, J., Wang, D., & Li, W. (2021) · Journal of International Medical Research · doi:10.1177/03000605211032807 · Cited by 9
Li, Y., Wang, H., Chen, M., & Ma, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.872991 · Cited by 9
Zheng, C., Zhang, G., Xie, K., Diao, Y., Luo, C., Wang, Y., Shen, Y., & Xue, Q. (2022) · Cancers · doi:10.3390/cancers14184522 · Cited by 9
Huang, H., Du, Y., Zhao, D., & Chen, K. (2022) · Journal of Oncology · doi:10.1155/2022/1040116 · Cited by 9
Anticancer Tetrahydrocarbazoles: A Wide Journey from 2000 Till Date
Kumar, N., & Gupta, P. (2022) · Letters in Drug Design & Discovery · doi:10.2174/1570180820666221028163319 · Cited by 9
Zhang, C., Chen, W., Pan, S. Y., Zhang, S., Xie, H., Zhang, Z., Lei, W., Bao, L., & You, Y. (2023) · Cell Death Discovery · doi:10.1038/s41420-022-01262-4 · Cited by 9
Cheng, H. W., Li, Y., Cheng, J., Zhang, Y., & Zhang, B. (2023) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2023.2217611 · Cited by 9
Non-coding RNA therapeutics: Towards a new candidate for arsenic-induced liver disease
Sun, J., Wu, L., Wu, M., Liu, Q., & Cao, H. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110626 · Cited by 9
Yasmin, I. A., Dharmarajan, A., & Warrier, S. R. (2023) · Cancers · doi:10.3390/cancers15143622 · Cited by 9
Wu, Z., Su, R., Dai, Y., Wu, X. F., Wu, H., Wang, X., Wang, Z., Bao, J., Chen, J., & Xia, E. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108666 · Cited by 9
Self-citationGuan, B., Huang, C., Meng, L., Zhang, S., Liu, Q., Wang, X., Li, X., & Hao, Z. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112599 · Cited by 9
Han, S., Jiang, X., Sun, X., Zhang, H., Li, C., Zhao, Z., & Yu, W. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111568 · Cited by 9
LDOC1 as Negative Prognostic Marker for Vulvar Cancer Patients
Wanka, G., Schmoeckel, E., Mayr, D. C., Fuerst, S., Kühn, C., Mahner, S., Knabl, J., Karsten, M. M., Dannecker, C., Heidegger, H. H., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239287 · Cited by 9
Wei, T., Song, J., Liang, K., Li, L., Mo, X., Huang, Z., Chen, G., Mao, N., & Yang, J. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03489-z · Cited by 9
Qin, M., Xu, M., Niu, L., Cheng, Y., Niu, X., Kong, J., Zhang, X., Wei, Y., & Huang, D. (2021) · Frontiers of Materials Science · doi:10.1007/s11706-021-0543-y · Cited by 9
Li, G., Zhu, X., & Liu, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.639059 · Cited by 9
Lee, G., Park, H., Lee, H. Y., Ahn, J., Sohn, I., Lee, S.-H., & Kim, J. (2021) · Cancers · doi:10.3390/cancers13071676 · Cited by 9
Morello, G., Cancila, V., Rosa, M. L., Germano, G., Lecis, D., Amodio, V., Zanardi, F., Iannelli, F., Greco, D., Paglia, L. L., et al. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0645 · Cited by 10
Lyu, X., Wang, P., Qiao, Q., & Jiang, Y. (2021) · BMC Cancer · doi:10.1186/s12885-021-08350-1 · Cited by 9
Li, S., Liu, Y., Liu, X., Lan, B., Li, W., & Guo, F. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s312823 · Cited by 9
Zhao, C., Liu, Y., Ju, S., & Wang, X. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s331752 · Cited by 9
Qi, W., Zhu, F., Wang, M., Teng, Z., Xu, R., Xi, Y., Meng, Q., Wu, X., Zhao, H., Ma, M., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.803981 · Cited by 9
Liu, Y., Liu, X., Xu, Q.-L., Gao, X., & Linghu, E. (2022) · In Vivo · doi:10.21873/invivo.12762 · Cited by 9
Xu, L., Hu, Y., & Liu, W. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.840348 · Cited by 9
Liquid biopsy for the assessment of adrenal cancer heterogeneity: where do we stand?
Perge, P., Nyírő, G., Vékony, B., & Igaz, P. (2022) · Endocrine · doi:10.1007/s12020-022-03066-z · Cited by 10
Geng, H., Dong, Z., Zhang, L., Yang, C. G., Li, T., Lin, Y., Ke, S., Xia, X., Zhang, Z., Zhao, G., et al. (2022) · Cancers · doi:10.3390/cancers14133276 · Cited by 9
Perrone, M., Raimondi, E., Costa, M., Rasetto, G., Rizzati, R., Lanza, G., Gafà, R., Cavallesco, G., Tamburini, N., Maniscalco, P., et al. (2022) · Cancers · doi:10.3390/cancers14143335 · Cited by 8
Comparative characteristics of small cell lung cancer and Ewing’s sarcoma: a narrative review
Hamilton, G. (2022) · Translational Lung Cancer Research · doi:10.21037/tlcr-22-58 · Cited by 9
dos Santos, N. J., Camargo, A. C. L., Carvalho, H. F., Justulin, L. A., & Felisbino, S. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169224 · Cited by 9
Tan, J., Xuhui, F., Wu, H., Yang, B., Shi, M., Xie, C. L., Su, Z., Li, L., Luo, M., Zuo, Z., et al. (2022) · Journal of Immunology Research · doi:10.1155/2022/6568278 · Cited by 9
Sun, D., Zhang, H., Zhang, C., & Wang, L. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.993820 · Cited by 9
Ding, W., Jiang, H., Ye, N., Zhuang, L., Yuan, Z., Tan, Y., Xue, W., & Xu, X. (2023) · Journal of Oncology · doi:10.1155/2023/8538240 · Cited by 9
Tan, M., Li, X., Chen, H., Ye, W., Yi, J., Li, C., Liu, J., & Su, J. (2023) · PeerJ · doi:10.7717/peerj.15203 · Cited by 9
The ratiometric fluorescence nanoparticle based on SiRB for pH detection of tumor
Wang, Q., Ding, X., Wang, Y., Du, Q., Xu, T., Du, B., & Yao, H. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.03.015 · Cited by 9
Pichler, R., Lindner, A. K., Compérat, É., Obrist, P., Schäfer, G., Todenhöfer, T., Horninger, W., Čulig, Z., & Untergasser, G. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.10.018 · Cited by 9
Jeong, Y., Kim, T., Hwang, E. J., Kim, S., Sonntag, K., Kim, D. H., & Koh, J. W. (2020) · Biomedical Materials · doi:10.1088/1748-605x/ab9bb2 · Cited by 9
Du, B., Zhou, Y., Yi, X., Zhao, T., Tang, C., Shen, T., Zhou, K., Wei, H., Xu, S. H., Dong, J., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01770 · Cited by 9
Migliari, S., Sammartano, A., Scarlattei, M., Baldari, G., Silva, C., & Ruffini, L. (2020) · Current Radiopharmaceuticals · doi:10.2174/1874471013666200929125102 · Cited by 9
Hierarchical Clustering of Cutaneous Melanoma Based on Immunogenomic Profiling
Yu, J., Xie, M., Ge, S., Chai, P., Zhou, Y., & Ruan, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.580029 · Cited by 9
Yan, H., Chen, Y., Yang, Z., Li, Z., Che, X., Xiao, J., Liu, Y., & Qu, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.621623 · Cited by 9
Development of a lncRNA‐based prognostic signature for oral squamous cell carcinoma
Xu, Z., Li, X., Pan, L., Tan, R., Ji, P., & Tang, H. (2022) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.13281 · Cited by 9
Wang, H., Liu, W., Zhao, Y., Hu, H., Zhang, B., & Yang, S. (2022) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.13909 · Cited by 8
Construction and validation of a bladder cancer risk model based on autophagy-related genes
Shen, C., Yan, Y., Yang, S., Wang, Z., Wu, Z., Li, Z., Zhang, Z., Lin, Y., Li, P., & Hu, H. (2023) · Functional & Integrative Genomics · doi:10.1007/s10142-022-00957-2 · Cited by 8
Kang, Y., Yeo, M., Choi, H., Jun, H., Eom, S., Park, S. G., Yoon, H., Kim, E., & Kang, S. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123577 · Cited by 8
Feng, Z., Cui, G., Tan, J., Liu, P., Chen, Y., Jiang, Z., Han, Y., Zeng, S., Shen, H., & Cai, C. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167017 · Cited by 8
Ogilvie, L. M., Coyle‐Asbil, B., Brunt, K. R., Petrik, J., & Simpson, J. A. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00795.2023 · Cited by 9
Guo, Y., Chen, M., Yang, J., Zhou, W., Feng, G., Wang, Y., Ji, T., Zhang, Y., & Liu, Z. (2024) · Oral Diseases · doi:10.1111/odi.15130 · Cited by 8
Song, Q., Sui, J., Yang, Y., Zhang, H., Li, Y., & Yang, L. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.139273 · Cited by 9
Effect of ultrasound combined with microbubbles therapy on tumor hypoxic microenvironment
Feng, Y., Qiu, D., He, Y., Jin, H., Chen, L., Xi, F., Hu, Z., Xie, Y., Li, Y., Lin, H.-T., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1502349 · Cited by 8
Cai, F., Mao, S., Peng, S., Wang, Z., Li, W., Zhang, R., Zhang, S., Sun, A., & Zhang, S. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114105 · Cited by 8
Sun, H., Wang, G., Ren, C., Zhang, X., Zhao, P., & Guo, B. (2025) · Scientific Reports · doi:10.1038/s41598-025-99383-0 · Cited by 8
Hartner, S., Abolfathi, H., Rezanejad, M., Liu, B., Karimi, E., Rogers, D., Sorin, M., Doré, S., Desharnais, L., Orain, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63465-4 · Cited by 10
Esophageal cancer: from pathogenesis to precision therapies
Zhang, S., Shen, Y., Zhu, L., Lai, Y., Zhu, L. C., Xiao, X., Li, J., Tan, W., Lin, D., & Wu, C. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02614-7 · Cited by 12
Zhu, Q., Deng, X., Yao, W., Chen, Z., Ye, Y., Gao, L., Zhang, W., Liu, W., & Zhao, S. (2021) · Annals of Hematology · doi:10.1007/s00277-020-04389-5 · Cited by 8
ALK is frequently phosphorylated in Merkel cell carcinoma and associates with longer survival
Jaatinen, J., Veija, T., Salmikangas, M., Böhling, T., Sihto, H. J., & Koljonen, V. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252099 · Cited by 8
Tumor Cell Secretomes in Response to Anti- and Pro-Tumorigenic Agents
Liu, S., Sun, X., Li, K., Lin, C., Na, S., Li, B., & Yokota, H. (2021) · Onco · doi:10.3390/onco1020009 · Cited by 8
Zhou, J., Guo, H., Liu, L., Feng, M.-L., Yang, X., & Hao, S. (2022) · Aging · doi:10.18632/aging.204302 · Cited by 8
Jia, H., Cao, M., Hao, S., Wang, J., & Wang, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-20162-2 · Cited by 8
Fan, T., Lü, J., Niu, D., Zhang, Y., Wang, B., Zhang, B., Zhang, Z., He, X., Peng, N., Li, B., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1046121 · Cited by 8
Gao, C., Liu, F., Ye, Q., & Guo, A. (2023) · Journal of Oncology · doi:10.1155/2023/1424589 · Cited by 8
Xu, S., Gao, X., Qiu, J., Hong, F., Gao, F., Wang, X., & Zhang, S. (2023) · Aging · doi:10.18632/aging.204529 · Cited by 8
Xiao, B., Li, M., Cui, M., Yin, C., & Zhang, B. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1131525 · Cited by 8
Qiao, L., Gong, X., Jia, G., Wu, J., Liu, S., Song, K., & Tian, G. (2023) · Molecular Medicine Reports · doi:10.3892/mmr.2023.13029 · Cited by 8
Meng, C., Xie, X., Qian, J., Tao, W., Wu, H., Ji, D., Gao, G., Wang, R., Ling, C., Zhang, Y., et al. (2023) · Materials & Design · doi:10.1016/j.matdes.2023.112251 · Cited by 8
Tumorigenic effects of human mesenchymal stromal cells and fibroblasts on bladder cancer cells
Frerichs, L. M., Frerichs, B., Petzsch, P., Köhrer, K., Windolf, J., Bittersohl, B., Hoffmann, M. J., & Grotheer, V. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1228185 · Cited by 9
Liu, S., Yao, Y., Hou, M., Mei, J., Sun, L., & Zhang, G. (2023) · BMC Cancer · doi:10.1186/s12885-023-11589-5 · Cited by 8
Zhao, H., Huang, Y., Tong, G., Wu, W., & Ren, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216188 · Cited by 8
Exploring the Immune Landscape of ccRCC : Prognostic Signatures and Therapeutic Implications
Pan, M., Xu, X., Zhang, D., & Cao, W. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70212 · Cited by 8
Metadata
- Authors
- Wu, T., & Dai, Y.
- Affiliations
- Peking University First Hospital (CN)
- Corresponding author
- Dai, Yun
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2017-02
- Volume
- 387
- Pages
- 61-68
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2265419075
- Cited by
- 1,802
- References
- 124
- Citations by year
- 2026: 76 · 2025: 179 · 2024: 238 · 2023: 344 · 2022: 382 · 2021: 316 · 2020: 191 · 2019: 48 · 2018: 20 · 2017: 5
- FWCI
- 2.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Letters (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- tumor microenvironment, treatment resistance, drug resistance, stromal fibroblasts, extracellular matrix, cell adhesion, immune cells, immune reprogramming, combination therapy, soluble factors
- MeSH terms
- Animals, Antineoplastic Agents, Humans, Neoplasms, Molecular Targeted Therapy, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review